A natural PKM2 targeting agent as a potential drug for breast cancer treatment
A natural PKM2 targeting agent as a potential drug for breast cancer treatment
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
The results showed a concentration-dependent decrease in the viability of breast cancer cells after treatment with YHC (Figure S1A–C). [...]YHC was less toxic than positive controls (Dox and Tam) on human normal breast epithelial cells MCF-10A cells (Figure S2). A peak corresponding to pyruvate kinase M2 (PKM2) was identified by mass spectrometry,...
Alternative Titles
Full title
A natural PKM2 targeting agent as a potential drug for breast cancer treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0f8076d2d9e143ca8fa09beadc2786b5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0f8076d2d9e143ca8fa09beadc2786b5
Other Identifiers
ISSN
2001-1326
E-ISSN
2001-1326
DOI
10.1002/ctm2.1157
